MBX Biosciences (MBX) Retained Earnings (2023 - 2026)
MBX Biosciences (MBX) reported Retained Earnings of -$248.0 million for Q1 2026, down 53.67% on a YoY basis from -$535.3 million in Q1 2025, and down 86813.29% sequentially from $286000.0 in Q4 2025.
MBX Biosciences (MBX) Retained Earnings (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Retained Earnings data on file, last reported at -$248.0 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 53.67% year-over-year to -$248.0 million; the trailing twelve-month figure through Mar 2026 stood at -$248.0 million (down 53.67% YoY), and the FY2025 full-year result was $286000.0, up 420.0% from the prior year.
- Retained Earnings retreated to -$248.0 million in Q1 2026, from $286000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $286000.0 in Q4 2025 to a low of -$248.0 million in Q1 2026.
- A 4-year average of -$88.9 million and a median of -$60.9 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings soared 420.0% in 2025 and sank 53.67% in 2026, its largest moves.
- Tracing MBX's Retained Earnings over 4 years: stood at $60000.0 in 2023, then slipped by 8.33% to $55000.0 in 2024, then soared by 420.0% to $286000.0 in 2025, then slumped by 86813.29% to -$248.0 million in 2026.
- Business Quant data shows MBX's Retained Earnings at -$248.0 million in Q1 2026, $286000.0 in Q4 2025, and $154000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - | -248.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -248.00 Mn |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | -180.80 Mn |
| Mar 31, 2025 | -161.39 Mn |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | -121.90 Mn |
| Dec 31, 2023 | 60,000.00 |